Georgia Healthcare Group PLC Annual Report 2018 Strategic Report Financial highlights The effectiveness of our strategy is reflected in the record 2018 financial results highlighted below. Revenue (GEL million)1 Total assets (GEL million) 849.9 2018 849.9 1,240.5 2018 1,240.5 +13.7% y-o-y 2017 747.8 +5.1% y-o-y 2017 1,180.8 2016 426.4 2016 915.4 Gross profit (GEL million) Pharmacy and distribution gross profit margin (%) 268.6 2018 268.6 25.5 2018 25.5 +17.8% y-o-y 2017 228.0 +1.0 ppts y-o-y 2017 24.5 2016 146.0 2016 20.7 EBITDA (GEL million) Healthcare services EBITDA margin (%) 132.3 2018 132.3 24.9 2018 24.9 +22.3% y-o-y 2017 108.1 -1.5 ppts y-o-y 2017 26.4 2016 78.0 2016 30.2 Pharmacy and distribution EBITDA margin (%) Profit before tax (GEL million) 10.1 2018 10.1 53.9 2018 53.9 +1.5 ppts y-o-y 2017 8.6 +16.3% y-o-y 2017 46.3 2016 4.3 2016 40.2 Earnings per share (GEL) Return on invested capital (%) (adjusted) 3 0.27 2018 0.27 13.9 2018 13.9 +17.4% y-o-y 2017 0.23 +1.1 ppts y-o-y 2017 12.8 20162 0.24 2016 9.0 1The amount represents gross revenue before corrections and rebates (see Financial Statements, Note 3). Revenue net of corrections and rebates was GEL 846.3 million in 2018 (2017: GEL 745.7, 2016: GEL 423.8 million). 22016 earnings per share (“EPS”) is calculated as normalised net profit divided by weighted average number of shares outstanding during the same period. 3Return on invested capital (“ROIC”) is adjusted to exclude newly launched hospitals and polyclinics that are in roll-out phase. 2